NCT04424992 The Natural History of Hospitalized COVID-19 Patients
| NCT ID | NCT04424992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Milano Bicocca |
| Condition | Sars-CoV2 |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,433 participants |
| Start Date | 2020-02-28 |
| Primary Completion | 2025-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,433 participants in total. It began in 2020-02-28 with a primary completion date of 2025-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational study. The aim is to describe the natural history and clinical evolution over time of hospitalized patients affected by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV-2) infection, including the genetic pathology of the disease and improve therapeutic procedures.
Eligibility Criteria
Inclusion Criteria: 1. Clinical and / or radiological diagnosis of lung infection with COVID-19; 2. Positive test for SARS-CoV-2 infection. Exclusion Criteria: 1\. Age less than 18 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04424992 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sars-CoV2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04424992 currently recruiting?
Yes, NCT04424992 is actively recruiting participants. Contact the research team at paolo.bonfanti@unimib.it for enrollment information.
Where is the NCT04424992 trial being conducted?
This trial is being conducted at Monza, Italy.
Who is sponsoring the NCT04424992 clinical trial?
NCT04424992 is sponsored by University of Milano Bicocca. The trial plans to enroll 1,433 participants.